Oncobiomix
About Oncobiomix
Oncobiomix is a Technology company based in San Antonio (United States) founded in 2023. AI-driven insights for prostate cancer risks are delivered. Oncobiomix has raised $480 thousand across 1 funding round. Its chief executive, as recorded, is Michael Andre Liss. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Oncobiomix was established in 2023 in San Antonio, United States. An AI-based platform is maintained to generate disease insights specifically for prostate cancer. Deep learning techniques are applied within the healthcare and biotech fields to produce real-time predictions and risk assessments for patients. Operations center on utilizing artificial intelligence to support clinical decision-making in oncology. The team is headed by CEO Michael Andre Liss.
- Headquarters San Antonio, United States
- SectorsTechnology
- Total Equity Funding$480K (USD)
in 1 rounds
- Latest Funding Round$480K (USD), Seed
Oct 2023
Funding Insights of Oncobiomix
Oncobiomix has successfully raised a total of $480K through 1 strategic funding round. The most recent funding activity was a Seed round of $480 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $480,000
- Total Rounds 1
- Last Round Seed — $480,000
- First Round $480,000
(Oct 2023)
All 1 funding rounds of Oncobiomix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $480,000 | Seed | – | – | – |
People of Oncobiomix
1 people are tracked at Oncobiomix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Michael Andre Liss | CEO | Leadership |
Complete people profiles for Oncobiomix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oncobiomix
2 dated milestones of Oncobiomix, from founding to its latest funding, stage changes and deals.
- Founded Oncobiomix is founded.
- Funding First funding round of $480K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oncobiomix
Oncobiomix was founded in 2023.
Oncobiomix is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Michael Andre Liss is the CEO of Oncobiomix, as recorded in our data.
Oncobiomix is a funded company, having raised a total of $480K across 1 funding round to date. The company's 1st funding round was a Seed of $480K, raised on Oct 2023.
Oncobiomix was established in 2023 in San Antonio, United States. An AI-based platform is maintained to generate disease insights specifically for prostate cancer. Deep learning techniques are applied within the healthcare and biotech fields to produce real-time predictions and risk assessments for patients. Operations center on utilizing artificial intelligence to support clinical decision-making in oncology. The team is headed by CEO Michael Andre Liss.